UniProt ID | VGFR1_MOUSE | |
---|---|---|
UniProt AC | P35969 | |
Protein Name | Vascular endothelial growth factor receptor 1 | |
Gene Name | Flt1 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 1333 | |
Subcellular Localization |
Cell membrane Single-pass type I membrane protein. Endosome. Autophosphorylation promotes ubiquitination and endocytosis.. |
|
Protein Description | Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFA, VEGFB and PGF, and plays an essential role in the development of embryonic vasculature, the regulation of angiogenesis, cell survival, cell migration, macrophage function, chemotaxis, and cancer cell invasion. May play an essential role as a negative regulator of embryonic angiogenesis by inhibiting excessive proliferation of endothelial cells. Can promote endothelial cell proliferation, survival and angiogenesis in adulthood. Its function in promoting cell proliferation seems to be cell-type specific. Promotes PGF-mediated proliferation of endothelial cells, and proliferation of some types of cancer cells, but does not promote proliferation of normal fibroblasts. Has very high affinity for VEGFA and relatively low protein kinase activity; may function as a negative regulator of VEGFA signaling by limiting the amount of free VEGFA and preventing its binding to KDR. Modulates KDR signaling by forming heterodimers with KDR. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate and the activation of protein kinase C. Mediates phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, leading to the activation of phosphatidylinositol kinase and the downstream signaling pathway. Mediates activation of MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Phosphorylates SRC, YES1 and PLCG, and may also phosphorylate CBL. Promotes phosphorylation of AKT1 and PTK2/FAK1 (By similarity).. | |
Protein Sequence | MVSCWDTAVLPYALLGCLLLTGYGSGSKLKVPELSLKGTQHVMQAGQTLFLKCRGEAAHSWSLPTTVSQEDKRLSITPPSACGRDNRQFCSTLTLDTAQANHTGLYTCRYLPTSTSKKKKAESSIYIFVSDAGSPFIEMHTDIPKLVHMTEGRQLIIPCRVTSPNVTVTLKKFPFDTLTPDGQRITWDSRRGFIIANATYKEIGLLNCEATVNGHLYQTNYLTHRQTNTILDVQIRPPSPVRLLHGQTLVLNCTATTELNTRVQMSWNYPGKATKRASIRQRIDRSHSHNNVFHSVLKINNVESRDKGLYTCRVKSGSSFQSFNTSVHVYEKGFISVKHRKQPVQETTAGRRSYRLSMKVKAFPSPEIVWLKDGSPATLKSARYLVHGYSLIIKDVTTEDAGDYTILLGIKQSRLFKNLTATLIVNVKPQIYEKSVSSLPSPPLYPLGSRQVLTCTVYGIPRPTITWLWHPCHHNHSKERYDFCTENEESFILDPSSNLGNRIESISQRMTVIEGTNKTVSTLVVADSQTPGIYSCRAFNKIGTVERNIKFYVTDVPNGFHVSLEKMPAEGEDLKLSCVVNKFLYRDITWILLRTVNNRTMHHSISKQKMATTQDYSITLNLVIKNVSLEDSGTYACRARNIYTGEDILRKTEVLVRDSEAPHLLQNLSDYEVSISGSTTLDCQARGVPAPQITWFKNNHKIQQEPGIILGPGNSTLFIERVTEEDEGVYRCRATNQKGAVESAAYLTVQGTSDKSNLELITLTCTCVAATLFWLLLTLFIRKLKRSSSEVKTDYLSIIMDPDEVPLDEQCERLPYDASKWEFARERLKLGKSLGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKILTHIGHHLNVVNLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKRDLFCLNKDAALHMELKKESLEPGLEQGQKPRLDSVSSSSVTSSSFPEDRSVSDVEGDEDYSEISKQPLTMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRRGDTRLPLKWMAPESIFDKVYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLKEGMRMRTPEYATPEIYQIMLDCWHKDPKERPRFAELVEKLGDLLQANVQQDGKDYIPLNAILTRNSSFTYSTPTFSEDLFKDGFADPHFHSGSSDDVRYVNAFKFMSLERIKTFEELSPNSTSMFEDYQLDTSTLLGSPLLKRFTWTETKPKASMKIDLRIASKSKEAGLSDLPRPSFCFSSCGHIRPVQDDESELGKESCCSPPPDYNSVVLYSSPPA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
101 | N-linked_Glycosylation | TLDTAQANHTGLYTC EECHHHHCCCCEEEE | 22.60 | - | |
165 | N-linked_Glycosylation | PCRVTSPNVTVTLKK EEEECCCCEEEEEEE | 41.69 | - | |
197 | N-linked_Glycosylation | RRGFIIANATYKEIG CCCEEEECCEEEEEC | 23.54 | - | |
200 | Phosphorylation | FIIANATYKEIGLLN EEEECCEEEEECEEE | 12.29 | - | |
252 | N-linked_Glycosylation | HGQTLVLNCTATTEL CCCEEEEECEEECCC | 17.39 | - | |
324 | N-linked_Glycosylation | GSSFQSFNTSVHVYE CCCCCEEEEEEEEEE | 36.37 | - | |
357 | Phosphorylation | GRRSYRLSMKVKAFP CCCEEEEEEEEEECC | 13.93 | 30387612 | |
418 | N-linked_Glycosylation | KQSRLFKNLTATLIV CHHHCCCCCEEEEEE | 34.98 | - | |
475 | N-linked_Glycosylation | LWHPCHHNHSKERYD EECCCCCCCCHHHEE | 19.91 | - | |
517 | N-linked_Glycosylation | MTVIEGTNKTVSTLV EEEEECCCCEEEEEE | 49.19 | - | |
598 | N-linked_Glycosylation | ILLRTVNNRTMHHSI EEEEECCCCHHCCCC | 36.14 | - | |
626 | N-linked_Glycosylation | TLNLVIKNVSLEDSG EEEEEEECCCHHHCC | 19.93 | - | |
667 | N-linked_Glycosylation | EAPHLLQNLSDYEVS CCCHHHHCCCCCEEE | 41.29 | - | |
671 | Phosphorylation | LLQNLSDYEVSISGS HHHCCCCCEEEECCC | 18.17 | 22871156 | |
674 | Phosphorylation | NLSDYEVSISGSTTL CCCCCEEEECCCCEE | 10.09 | 22871156 | |
676 | Phosphorylation | SDYEVSISGSTTLDC CCCEEEECCCCEECH | 21.13 | 22871156 | |
714 | N-linked_Glycosylation | GIILGPGNSTLFIER CEEECCCCCEEEEEE | 34.65 | - | |
792 | Ubiquitination | KRSSSEVKTDYLSII HCCCCCCCCCEEEEE | 31.46 | 22790023 | |
820 | Ubiquitination | RLPYDASKWEFARER CCCCCHHHHHHHHHH | 53.08 | 22790023 | |
841 | Ubiquitination | LGRGAFGKVVQASAF CCCCHHHHHHHHHHH | 32.55 | 22790023 | |
851 | Ubiquitination | QASAFGIKKSPTCRT HHHHHCCCCCCCCHH | 47.80 | 22790023 | |
865 | Ubiquitination | TVAVKMLKEGATASE HHHHHHHHCCCCHHH | 51.07 | 22790023 | |
869 | Phosphorylation | KMLKEGATASEYKAL HHHHCCCCHHHHHHH | 41.39 | 21454597 | |
871 | Phosphorylation | LKEGATASEYKALMT HHCCCCHHHHHHHHH | 36.78 | 21454597 | |
873 | Phosphorylation | EGATASEYKALMTEL CCCCHHHHHHHHHHH | 10.08 | 21454597 | |
915 | Phosphorylation | VIVEYCKYGNLSNYL EEEEEECCCCHHHHH | 14.00 | 28576409 | |
919 | Phosphorylation | YCKYGNLSNYLKSKR EECCCCHHHHHHHCH | 27.68 | 28576409 | |
921 | Phosphorylation | KYGNLSNYLKSKRDL CCCCHHHHHHHCHHE | 16.48 | 28576409 | |
924 | Phosphorylation | NLSNYLKSKRDLFCL CHHHHHHHCHHEEEC | 30.26 | 28576409 | |
943 | Ubiquitination | ALHMELKKESLEPGL HHHHHHHHHHCCCCH | 66.22 | - | |
955 | Ubiquitination | PGLEQGQKPRLDSVS CCHHCCCCCCCCCCC | 38.64 | 22790023 | |
976 | Phosphorylation | SSFPEDRSVSDVEGD CCCCCCCCCCCCCCC | 37.99 | - | |
978 | Phosphorylation | FPEDRSVSDVEGDED CCCCCCCCCCCCCCC | 36.87 | - | |
995 | Phosphorylation | EISKQPLTMEDLISY HHHCCCCCHHHHHHH | 25.79 | 30635358 | |
1001 | Phosphorylation | LTMEDLISYSFQVAR CCHHHHHHHHHHHHH | 23.25 | 30635358 | |
1002 | Phosphorylation | TMEDLISYSFQVARG CHHHHHHHHHHHHHH | 13.40 | 30635358 | |
1003 | Phosphorylation | MEDLISYSFQVARGM HHHHHHHHHHHHHHC | 11.47 | 30635358 | |
1014 | Phosphorylation | ARGMEFLSSRKCIHR HHHCHHHHCCCCHHH | 33.16 | 30635358 | |
1015 | Phosphorylation | RGMEFLSSRKCIHRD HHCHHHHCCCCHHHH | 37.60 | 30635358 | |
1048 | Phosphorylation | FGLARDIYKNPDYVR CCCCCHHHHCCCCCC | 14.70 | 22817900 | |
1049 | Ubiquitination | GLARDIYKNPDYVRR CCCCHHHHCCCCCCC | 63.44 | 22790023 | |
1053 | Phosphorylation | DIYKNPDYVRRGDTR HHHHCCCCCCCCCCC | 9.34 | 22817900 | |
1121 | Phosphorylation | KEGMRMRTPEYATPE HCCCCCCCCCCCCHH | 15.89 | 28576409 | |
1124 | Phosphorylation | MRMRTPEYATPEIYQ CCCCCCCCCCHHHHH | 19.58 | 28576409 | |
1126 | Phosphorylation | MRTPEYATPEIYQIM CCCCCCCCHHHHHHH | 22.13 | 28576409 | |
1130 | Phosphorylation | EYATPEIYQIMLDCW CCCCHHHHHHHHHHH | 7.13 | 28576409 | |
1153 | Ubiquitination | RFAELVEKLGDLLQA HHHHHHHHHHHHHHH | 50.74 | 22790023 | |
1169 | Phosphorylation | VQQDGKDYIPLNAIL HCCCCCCCEEHHHEE | 14.13 | 27180971 | |
1184 | Phosphorylation | TRNSSFTYSTPTFSE ECCCCCCCCCCCCCH | 14.45 | - | |
1205 | Phosphorylation | FADPHFHSGSSDDVR CCCCCCCCCCCCCCE | 39.15 | 23375375 | |
1207 | Phosphorylation | DPHFHSGSSDDVRYV CCCCCCCCCCCCEEE | 33.34 | 27742792 | |
1208 | Phosphorylation | PHFHSGSSDDVRYVN CCCCCCCCCCCEEEE | 41.16 | 27742792 | |
1213 | Phosphorylation | GSSDDVRYVNAFKFM CCCCCCEEEEEEEEE | 9.63 | - | |
1218 | Ubiquitination | VRYVNAFKFMSLERI CEEEEEEEEEEHHHC | 37.43 | 22790023 | |
1242 | Phosphorylation | STSMFEDYQLDTSTL CCCCCCCCCCCHHHH | 12.08 | - | |
1259 | Phosphorylation | SPLLKRFTWTETKPK CHHHHCEECCCCCCC | 35.19 | 17203969 | |
1261 | Phosphorylation | LLKRFTWTETKPKAS HHHCEECCCCCCCCC | 30.62 | 17203969 | |
1263 | Phosphorylation | KRFTWTETKPKASMK HCEECCCCCCCCCCE | 45.32 | 17203969 | |
1322 | Phosphorylation | CCSPPPDYNSVVLYS CCCCCCCCCCEEEEE | 18.34 | - | |
1328 | Phosphorylation | DYNSVVLYSSPPA-- CCCCEEEEECCCC-- | 8.76 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of VGFR1_MOUSE !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of VGFR1_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of VGFR1_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
LDLR_MOUSE | Ldlr | physical | 17962812 | |
CBL_MOUSE | Cbl | physical | 15001553 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Protein phosphorylation and expression profiling by Yin-yangmultidimensional liquid chromatography (Yin-yang MDLC) massspectrometry."; Dai J., Jin W.-H., Sheng Q.-H., Shieh C.-H., Wu J.-R., Zeng R.; J. Proteome Res. 6:250-262(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1263, AND MASSSPECTROMETRY. |